Our study reviewed different clotting (such as prothrombin time, thrombin time) and thrombophilia (such as protein C activity, antithrombin activity, free protein S) tests before and after DOAC-StopTM and DOAC Filter® treatments in a limited sample of four patients who were not on DOAC treatment. Here, F2 is linked to Rare hereditary thrombophilia.